Table 3.
Current 5-fold cross-validated accuracy scores are reported for line of therapy and cancer stage classification classes, and 5-fold cross-validated F1-scores are reported for the Clinical Trials Named Entity Recognition task.
|
|
Line of therapy, % | Cancer Stage, % | Clinical Trial, % |
| Fine-tuned BERTa model | 61 | 56 | 87 |
| Rule-based approach | 60 | 74 | —b |
aBERT: bidirectional encoder representations from transformers.
bNot available.